Annovis Bio, Inc. (ANVS)

NYSE: ANVS · Real-Time Price · USD

1.100

+0.060 (5.77%)

At close: Sep 17, 2026, 4:00 PM EDT

1.140

+0.040 (3.64%)

After-hours: Sep 17, 2026, 4:15 PM EDT

Annovis Bio Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	18.73	19.53	10.55	5.75	28.38	45.69
Cash & Short-Term Investments	18.73	19.53	10.55	5.75	28.38	45.69
Cash Growth	9.33%	85.11%	83.36%	-79.72%	-37.89%	465.79%
Prepaid Expenses	0.52	0.34	0.37	0.04	0.1	0.07
Other Current Assets	2.79	1.21	3.01	4.41	7.54	0.24
Total Current Assets	22.04	21.08	13.93	10.21	36.02	46
Total Assets	22.04	21.08	13.93	10.21	36.02	46

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Accounts Payable	3.33	2.59	2.31	1.29	3.96	0.69
Accrued Expenses	3.03	1.04	1.58	2.99	3.74	0.82
Total Current Liabilities	6.36	3.64	3.88	4.28	7.7	1.51
Other Long-Term Liabilities	19.93	0.6	0.74	13.68	-	-
Total Liabilities	26.29	4.23	4.62	17.96	7.7	1.51

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Common Stock	0	0	0	0	0	0
Additional Paid-In Capital	191.87	180.55	144.16	102.51	82.38	73.22
Retained Earnings	-196.13	-163.7	-134.85	-110.26	-54.05	-28.73
Total Common Equity	-4.25	16.85	9.31	-7.75	28.32	44.49
Shareholders' Equity	-4.25	16.85	9.31	-7.75	28.32	44.49
Total Liabilities & Equity	22.04	21.08	13.93	10.21	36.02	46

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Cash (Debt)	18.73	19.53	10.55	5.75	28.38	45.69
Net Cash Growth	9.33%	85.11%	83.36%	-79.72%	-37.89%	465.79%
Net Cash Per Share	0.68	0.95	0.86	0.64	3.48	5.99
Filing Date Shares Outstanding	42.61	28.36	19.49	11.01	8.22	8.16
Total Common Shares Outstanding	42.61	27.2	14.14	10.52	8.16	8.1
Working Capital	15.68	17.45	10.04	5.93	28.32	44.49
Book Value Per Share	-0.10	0.62	0.66	-0.74	3.47	5.49
Tangible Book Value	-4.25	16.85	9.31	-7.75	28.32	44.49
Tangible Book Value Per Share	-0.10	0.62	0.66	-0.74	3.47	5.49

SEC Filings: 10-K · 10-Q